News in brief: Provocatus names Luke Gartner as managing director; Nurotech’s FDA boost by Adam Sheldon and Martin Lane October 8, 2025October 8, 2025 Provocatus has announced a significant change to its executive team, with Luke Gartner named as its […]
Neurotech to release paediatric cannabis drug through Authorised Prescribers by Adam Sheldon September 24, 2025September 24, 2025
Dr Bonni Goldstein joins Neurotech push to register cannabis drug for paediatric patients by Steve Jones June 16, 2025June 16, 2025
PK study shows further promise for Neurotech paediatric CBDA drug by Steve Jones June 3, 2025June 3, 2025
News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024April 11, 2025
US FDA rejects Neurotech application for orphan drug status by Steve Jones October 8, 2024February 25, 2025
Neurotech seeks pharma partners for overseas drug development but will go it alone in Australia by Steve Jones August 12, 2024August 12, 2024
Cannabinoid drug developer holds ‘positive’ talks with TGA as hopes rise of fast-tracking ARTG listing by Steve Jones June 28, 2024June 28, 2024
Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities by Steve Jones April 17, 2024April 18, 2024
Neurotech reports positive results from latest trial of cannabinoid drug candidate NTI164 by Martin Lane October 6, 2023April 30, 2024
